Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.0%

152 terminated/withdrawn out of 799 trials

Success Rate

73.8%

-12.8% vs industry average

Late-Stage Pipeline

13%

104 trials in Phase 3/4

Results Transparency

57%

243 of 428 completed trials have results

Key Signals

109 recruiting243 with results86 terminated66 withdrawn

Enrollment Performance

Analytics

N/A
355(51.7%)
Phase 2
115(16.7%)
Phase 4
85(12.4%)
Phase 1
82(11.9%)
Early Phase 1
31(4.5%)
Phase 3
19(2.8%)
687Total
N/A(355)
Phase 2(115)
Phase 4(85)
Phase 1(82)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (799)

Showing 20 of 799 trials
NCT01712620Phase 2Recruiting

Spironolactone for Pulmonary Arterial Hypertension

Role: collaborator

NCT06118268Not ApplicableRecruiting

iTBS to Enhance Social Cognition in People With Psychosis

Role: collaborator

NCT07244211Not ApplicableRecruiting

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Role: collaborator

NCT07846020Phase 1Not Yet Recruiting

Mechanistic Evaluation of Polypharmacy Effects for Pain

Role: lead

NCT01323322Active Not Recruiting

Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS)

Role: collaborator

NCT07227662Not ApplicableRecruiting

Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis

Role: lead

NCT07834294Completed

Ventilation During CPR and Return of Spontaneous Circulation

Role: collaborator

NCT05634733Recruiting

Change in MAPSE During Treatment of Sepsis

Role: lead

NCT06293469Not ApplicableRecruiting

Accelerated Flap Coverage in Severe Lower Extremity Trauma

Role: collaborator

NCT03299426Phase 3Active Not Recruiting

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Role: lead

NCT06735950Not ApplicableNot Yet Recruiting

The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD

Role: lead

NCT07826871Phase 2Not Yet Recruiting

Targeting HealthY Eating to Maintain Energy While Living With Cancer

Role: lead

NCT05615844Phase 3Recruiting

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

Role: lead

NCT05403723Phase 1Suspended

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Role: lead

NCT07537413Phase 4Not Yet Recruiting

Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

Role: lead

NCT07168486Phase 1Enrolling By Invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Role: lead

NCT01617161Not ApplicableActive Not Recruiting

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Role: collaborator

NCT06691243Phase 2Active Not Recruiting

Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

Role: lead

NCT07374796Not Yet Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Role: lead

NCT07558122Phase 1Not Yet Recruiting

Malaria CVD 36000; Gates INV090205

Role: lead